{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)
Status:
Investigational
Source:
NCT00770354: Phase 2 Interventional Terminated Breast Carcinoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00284804: Phase 2 Interventional Completed Hodgkin's Disease
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02448810: Phase 2 Interventional Terminated Metastatic Colorectal Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03587311: Phase 2 Interventional Active, not recruiting Fallopian Tube Endometrioid Adenocarcinoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01183897: Phase 2 Interventional Completed Neuroblastoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01015560: Phase 2 Interventional Completed Metastatic Cancer
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03659136: Phase 2 Interventional Completed Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02225366: Phase 1/Phase 2 Interventional Completed Melanoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04028063: Phase 2 Interventional Recruiting Metastatic Soft Tissue Sarcoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02785900: Phase 3 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
